The independent platform for news, articles and advice for professionals in laboratory medicine

Comment from BIVDA on Budget announcements

BIVDA, the UK’s leading association for in vitro diagnostics (IVD) technology and innovation, recently responded to Budget announcements from Chancellor Rishi Sunak.

This Budget comes at a crucial moment regarding protecting the UK’s health service through the winter as it tackles backlogs and readies itself for future public health threats.

The government must recognise the role of both the home-grown diagnostics industry from SME’s and larger companies operating in the UK in bolstering the NHS’s capacity for backlog reduction, providing data on COVID-19 test results and the new focus on community diagnostic care services which bring important health checks and detection methods to people on the ground. The IVD sector stands at the cusp on novel innovation, allowing for swifter and earlier diagnosis of disease using cutting-edge technologies. This is a key step in making the United Kingdom a science superpower. 

The Chancellor outlined a number of policies of interest and benefit to the UK IVD and life sciences sector, including a £5.9 billion package for NHS England to clear the care backlog, £5 billion for health-related R&D and an expansion of the new Community Diagnostic Centre network.

BIVDA CEO Doris-Ann Williams said: “The backlog funding package will help the NHS to alleviate the heavy pressure being placed on the service as 5.7 million people await care. BIVDA’s IVD member companies stand ready to play their part in the diagnostic process.

“It is essential that IVD companies of all sizes can access the R&D funding to develop novel diagnostics and bring them to market. The access to funding must be clearly signposted and we are pleased to see testing being brought closer to home in communities. This should reduce hospital visits with the number of centres increasing to achieve nationwide screening. The focus of further funding should be directed towards diagnostic testing in pathology, as well as imaging by radiology.”

www.bivda.org.uk

Upcoming Events

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025